A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia
Clinical trial NCT02087917 · COMPLETED
Trial details
- NCT number
- NCT02087917
- Sponsor
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-09-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.